ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
146 hedge funds and large institutions have $704M invested in iTeos Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 45 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+3
Holders Change %
+2.1%
% of All Funds
2.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
19
Increased
52
Reduced
45
Closed
15
Calls
$1.01M
Puts
$461K
Net Calls
+$553K
Net Calls Change
+$352K
Top Buyers
| 1 |
OCA
1
Octagon Capital Advisors
New York
|
$8.69M |
| 2 |
2
BlackRock
New York
|
$87.5M |
| 3 |
6CM
3
683 Capital Management
New York
|
$2.93M |
| 4 |
4
Millennium Management
New York
|
$17.1M |
| 5 |
5
Bank of America
Charlotte,
North Carolina
|
$9.23M |
